Bioavailability of a nanoemulsion of lutein is greater than a lutein supplement

Nano Biomedicine and Engineering

Volumn 1, Issue 1, 2009, Pages 38-49

  Vishwanathan, Rohini ^a   Wilson, Thomas A ^a   Nicolosi, Robert J ^a  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

Age related macular degeneration; Bioavailability; Lutein; Macular pigment; Nanoemulsions; Supplements

Indexed keywords

EID: 79953204843     PISSN: None     EISSN: 21505578     Source Type: Journal    
DOI: 10.5101/nbe.v1i1.p38-49     Document Type: Article

References (40)

1. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137: 486-495.
2. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-851.
3. Nolan J, O'Donovan O, Beatty S. The role of macular pigment in the defence against AMD. AMD 2003; 1: 39-41.
4. Ahmed SS, Lott MN, Marcus DM. The Macular Xantho-phylls. Surv Ophthalmol 2005; 50: 183-193.
5. Alves-Rodrigues A, Shao A. The science behind lutein. Toxicology Lett. 2004; 150: 57-83.
6. Roodenburg JC, Leenen R, van het hof KH, Weststrate JA, Tijburg LBM. Amount of fat in the diet affects bioavailability of lutein esters but not of α-carotene, β-carotene, and vitamin E in humans. Am J Clin Nutr 2000; 71: 1187-93.
7. Parker RS. Absorption, metabolism, and transport of carot-enoids. FASEB J 1996; 10: 542-551.
8. Chung HY, Rasmussen HHM, Johnson EJ. Lutein bioavailability if higher from lutein-enriched eggs than from supplements and spinach in men. J Nutr 2004; 134: 1887-1893.
9. Handelman GJ, Nightingale ZD, Lichtenstein AH, Schaefer EJ, Blumberg JB. Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk. Am J Clin Nutr 1999; 70: 247-51.
10. Goodrow EF, Wilson TA, Houde SC, Vishwanathan R, Scollin PA, Handelman GJ, Nicolosi RJ. Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein concentrations. J Nutr 2006; 36: 2519-2524.
11. Vishwanathan R, Goodrow-Kotyla EF, Wooten BR, Wilson TA, Nicolosi RJ. Consumption of 2 and 4 egg yolks/d for 5 wk increases macular pigment concentrations in older adults with low macular pigment taking cholesterol-lowering statins. Am J Clin Nutr 2009; 90: 1272-9.
12. Tadros T, Izquierdo P, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interface Sci 2004; 108-109: 303-318.
13. Chen H, Weiss J and Shahidi F. Nanotechnology in nutraceuticals and functional foods. Food Tech 2006;1: 30-36.
14. Kotyla T, Kuo F, Moolchandani V, Wilson TA, Nicolosi RJ. Increased bioavailability of a transdermal application of a nano-sized emulsion preparation. Int J Pharm 2008; 347: 144-148.
15. Kuo F, Subramanian B, Kotyla T, Wilson TA, Yoganathan S, Nicolosi RJ. Nanoemulsions of an anti-oxidant synergy formulation containing gamma-tocopherol have enhanced bioavailability and anti-inflammatory properties. Int J Pharm 2008; 363: 206-13.
16. Tiwari SB, Amiji MM. Improved oral deliver of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol 2006; 6: 3215-21.
17. Tagne JB, Kakumanu S, Ortiz D, Shea T, Nicolosi RJ. A nanoemulsion formulation of tamoxifen increases its effica-cy in breast cancer cell line. Mol Pharm 2007; 5: 280-286.
18. Tagne JB, Kakumanu S, Nicolosi RJ. Nanoemulsion preparations of the anti-cancer drug dacarbazine significantly increases its efficacy in a xenograft mouse melanoma model. Mol Pharm 2008; 5: 1055-1063.
19. Subramanian B, Kuo F, Ada E, Kotyla T, Wilson TA, Yoganathan S, Nicolosi RJ. Enhancement of anti-inflammatory property of aspirin in mice by a nano-emulsion preparation. Int Immunopharm 2008; 8: 1533-1539.
20. Thurmann PA, Schalch W, Aebischer JC, Tenter U, Cohn W. Plasma kinetics of lutein, zeaxanthin, and 3-dehydro-lutein after multiple doses of a lutein supplement. Am J Clin Nutr 2005; 82: 88-97.
21. Handelman GJ, Snodderly DM, Adler AJ, Russett MD, Dratz EA. Measurement of carotenoids in human and monkey retinas. Methods Enzymol 1992; 213: 220-30.
22. Steghens JP, van Kappel AL, Riboli E, Collombel C. Simultaneous measurement of seven carotenoids, retinol and alpha-tocopherol in serum by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997; 694: 71-81.
23. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.
24. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983; 29: 538-42.
25. Snedecor GW, Cochran WG, Ames IA. Statistical methods. The Iowa State University Press, 1980.
26. US Department of Agriculture. A R S. Nutrient Data Laboratory [homepage on the internet]. 1998 [cited 11/05], Available from: http://www.nal.usda.gov/fnic/foodcomp/search/.
27. Chen HS, Chang JH, Wu JSB. Calcium bioavailability of nanonized peal powder for adults. J Food Sci 2008; 73: 246-251.
28. Hatanka J, Kimura Y, Lai-Fu Z, Onoue S, Yamada S. Physicochemical and pharmacokinetic characterization of water-soluble coenzyme Q(10) formulations. Int J Pharm 2008; 363: 112-7.
29. Reis P, Ribeiro AJ, Houng S, Veiga F, Neufeld RJ. Nano-particulate delivery system for insulin: design, characterization and in vitro/in vivo bioavailability. Eur J Pharm Sci 2007; 30: 392-397.
30. Pires LA, Hegg R, Valduga CJ, Graziani SR, Rodrigues DG, Maranhao RC. Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study. Cancer Chemother Pharmacol 2009; 63: 281-287.
31. De Smidt PC, Campanero MA, Troconiz IF. Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int J Pharm 2004; 270: 109-118.
32. Borel P, Grolier P, Armand M, Partier A, Lafont H, Lairon D, Azais-Braesco V. Carotenoids in biological emulsions: solubility, surface-to-core distribution, and release from lipid droplets. J Lipid Res 1996; 37: 250-261.
33. Roodenburg AJC, Rianne L, van het Hof KH, Weststraten JA, Tijburg LBM. Amount of fat in the diet affects bioa-vailability of lutein esters but not of α-carotene, β-carotene, and vitamin E in humans. Am J Clin Nutr 2000; 71: 1187-793.
34. Tanumihardjo SA, Li J, Dosti MP. Lutein absorption if facilitated with cosupplementation of ascorbic acid in young adults. J Am Diet Assoc 2005; 105: 114-118.
35. Molldrem KL, Li J, Simon PW, Tanumihardjo SA. Lutein and β-carotene from lutein-containing yellow carrots are bioavailable in humans. Am J Clin Nutr 2004; 80: 131-136.
36. Tyssandier V, Cardinault N, Caris-Veyrat C, Amiot MJ, Grolier P, Bouteloup C, Azais-Braesco V, Borel P. Vegetable-borne lutein, lycopene, and β-carotene compete for incorporation into chylomicrons, with no adverse effect on the medium-term (3-wk) plasma status of carotenoids in humans. Am J Clin Nutr 2002; 75: 526-34.
37. Nii T, Ishii F. Dialkylphosphatidylcholine and egg yolk lecithin for emulsification of various triglycerides. Colloids Surf B Biointerfaces 2005; 41: 305-311.
38. Ishii F, Nii T. Properties of various phospholipid mixtures as emulsifiers or dispersing agents in nanoparticle drug carrier preparations. Colloids Surf B Biointerfaces 2005; 41: 257-262.
39. Code of Federal Regulations. 2008. 21CFR172.840.
40. Wooster TJ, Golding M, Sanguansri P. Impact of oil type on nanoemulsion formation and Ostwald ripening stability. Langmuir 2008; 24: 12758-12765.